Business / Finance

RSS

CareSouth Health System to commence national rebranding of CareSouth agencies

CareSouth Health System, Inc., a national senior living services provider based in Augusta, Ga., announced today that it will begin a national rebranding of its CareSouth agencies across all CareSouth branded business lines including CareSouth Home Health, CareSouth Hospice, CareSouth Private Duty and CS Health & Wellness.

7 Jan 2015

LSNE's Harvey Road facility receives approval to manufacture drug product for US distribution

Lyophilization Services of New England, Inc. announced today that following an FDA Pre-Approval Inspection (PAI) in November 2014, their Harvey Road manufacturing site has received approval to manufacture commercial drug product for US distribution.

7 Jan 2015

EnGeneIC closes oversubscribed Series B financing

EnGeneIC, Ltd., an emerging biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of cancer therapeutics, announced it has completed an oversubscribed $10 million Series B financing.

6 Jan 2015

Elsevier assumes publication of Neoplasia and Translational Oncology journals

Elsevier, a world-leading provider of scientific, technical and medical information products and solutions, has announced that it has acquired Neoplasia Press Inc. and assumes publication of its flagship journals, Neoplasia and Translational Oncology. These peer-reviewed, open access journals are now published by Elsevier under the Neoplasia Press imprint.

6 Jan 2015

Oncoceutics, MD Anderson partner to develop novel anti-cancer drug

Oncoceutics Inc. and The University of Texas MD Anderson Cancer Center today announced the initiation of a strategic alliance and research collaboration agreement for the clinical development of ONC201, a novel anti-cancer drug.

5 Jan 2015

Clementia secures additional $10 million to support development of palovarotene for treatment of FOP

Clementia Pharmaceuticals, Inc. today announced that it has secured an additional $10 million from current investors to support development of the company's lead compound palovarotene for the treatment of fibrodysplasia ossificans progressive (FOP).

5 Jan 2015

Catamaran acquires Salveo Specialty Pharmacy for $260 million

Catamaran Corp., a leading provider of pharmacy benefit management (PBM) services and technology solutions, announced today the completion, effective as of January 2, 2015, of its previously disclosed acquisition of Salveo Specialty Pharmacy, for a purchase price of $260 million in cash, subject to certain customary post-closing adjustments.

5 Jan 2015

Jopari Solutions, Noble House partner to advance medical billing and processing

Jopari Solutions, the principal supplier of medical EDI services and connectivity networks to Providers and Payers in Property & Casualty markets, and Noble House, a software leader for billing and claims management for DME/HME, today announced a strategic partnership to advance medical billing and processing.

5 Jan 2015

TxCell announces further enhancement to development of Ovasave for IBD treatment

Paulsen Foundation to provide specialist management and scientific and development expertise that is dedicated to advanced therapies, i.e. cellular and gene therapies. This new class of highly promising biological therapies includes TxCell’s Ovasave.

5 Jan 2015

Spark Therapeutics files Form S-1 registration statement for initial public offering of common stock

Spark Therapeutics announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock.

2 Jan 2015

Mimedx receives subpoena from Office of Inspector General, HHS

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today that it has received a subpoena from the Office of Inspector General ("OIG") of the Department of Health and Human Services ("HHS") in connection with a civil investigation into matters primarily related to the Company's sales and marketing activities.

2 Jan 2015

Elements Behavioral Health acquires Park Bench Group Counseling

Elements Behavioral Health, a leading nationwide provider of addiction and mental health treatment programs, announced today that it has acquired Park Bench Group Counseling, located in Southeastern New Jersey.

31 Dec 2014

OncoGenex executes initial agreement with Teva to regain rights to custirsen

OncoGenex Pharmaceuticals, Inc. today announced that it has executed an initial agreement with Teva Pharmaceutical Industries Ltd. to regain rights to custirsen, an investigational compound currently being evaluated in Phase 3 clinical development as a treatment for prostate and lung cancers.

31 Dec 2014

Lightpoint Medical raises $3.1M in Series A financing round for medical imaging technology

Lightpoint Medical, a developer of innovative surgical imaging technologies, announced today that the company has raised £2 million ($3.1 million) in a Series A financing round.

31 Dec 2014

ARC Healthcare declares common stock dividend for January 2015

American Realty Capital Healthcare Trust, Inc. announced today that, pursuant to the prior authorization of its board of directors, on January 15, 2015, ARC Healthcare will pay a distribution of $0.056666667 per share to stockholders of record at the close of business on January 8, 2015.

31 Dec 2014

Tikcro enters into research and license agreement with Yeda

Tikcro Technologies Ltd. today announced that it has entered into a research and license agreement with Yeda Research and Development Company Ltd., the technology transfer arm of the Weizmann Institute of Science in Israel.

30 Dec 2014

Abbott reports tender offer results to purchase 5.125% Senior Notes issued by CFR International SpA

Abbott today reported early results for the tender offer and related consent solicitation commenced by its wholly-owned subsidiary, Abbott Laboratories (Chile) Holdco (Dos) SpA, a Chilean corporation to purchase for cash any or all of the outstanding 5.125% Senior Notes due 2022 (the "Notes") issued by CFR International SpA, a Chilean corporation and subsidiary of ALH.

30 Dec 2014

Gannett Healthcare Group sold to OnCourse Learning

Gannett Co., Inc. today announced it has sold Gannett Healthcare Group to OnCourse Learning, an online education and training provider.

30 Dec 2014

MagnaChip launches new bio-sensor research collaboration

MagnaChip Semiconductor Corporation, a Korea-based designer and manufacturer of analog and mixed-signal semiconductor products, today announced it has launched a research collaboration focused on developing innovative, cost-effective silicon magnetic bio-sensor technology capable of monitoring extremely rare cells in blood.

30 Dec 2014

Janssen, Gilead to jointly develop darunavir-based, single-tablet regimen for HIV treatment

Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based, single-tablet regimen (STR) for the treatment of people living with HIV.

29 Dec 2014